91 related articles for article (PubMed ID: 2517493)
1. Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
Nishi T; Nakano R; Yagi S
Horm Res; 1989; 32(5-6):193-7. PubMed ID: 2517493
[TBL] [Abstract][Full Text] [Related]
2. Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
Nakano R; Nishi T
Obstet Gynecol; 1989 Apr; 73(4):617-21. PubMed ID: 2494622
[TBL] [Abstract][Full Text] [Related]
3. Feedback of estrogen in postmenopausal women.
Nishi T; Yagi S; Nakano R
Acta Obstet Gynecol Scand; 1987; 66(4):309-13. PubMed ID: 3122514
[TBL] [Abstract][Full Text] [Related]
4. D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men.
Rubio MA; Torres-Aleman I; Calle JR; Cabranes JA; Schally AV; Charro AL
J Clin Endocrinol Metab; 1987 Aug; 65(2):368-9. PubMed ID: 2954994
[TBL] [Abstract][Full Text] [Related]
5. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
6. Feedback mechanism in sulpiride-induced hyperprolactinaemia.
Nakano R; Yagi S
Br J Obstet Gynaecol; 1983 Apr; 90(4):350-4. PubMed ID: 6404292
[TBL] [Abstract][Full Text] [Related]
7. Alteration of feedback mechanism of estrogen on gonadotropin by sulpiride-induced hyperprolactinemia.
L'Hermite M; Delogne-Desnoeck J; Michaux-Duchene A; Robyn C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1132-6. PubMed ID: 233689
[TBL] [Abstract][Full Text] [Related]
8. Progesterone positive feedback on gonadotropin release in estrogen-primed postmenopausal women: central nervous system and pituitary as possible sites of action.
Nicoletti I; Filipponi P; Fedeli L; Palumbo R; Santori P; Santeusanio F; Brunetti P
J Clin Endocrinol Metab; 1981 Jul; 53(1):135-8. PubMed ID: 6787064
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
Oseko F; Morikawa K; Motohashi T; Aso T
Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
[TBL] [Abstract][Full Text] [Related]
10. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
Yagi S; Nakano R
Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
[TBL] [Abstract][Full Text] [Related]
11. Impaired LH-RH release by estrogen in women with sulpiride-induced hyperprolactinemia.
Aono T; Miyake A; Koike K; Tasaka K; Kurachi K
Endocrinol Jpn; 1984 Oct; 31(5):571-5. PubMed ID: 6440785
[TBL] [Abstract][Full Text] [Related]
12. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
Lachelin GC; Yen SS
J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
[TBL] [Abstract][Full Text] [Related]
13. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
14. Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women.
Kolp LA; Pavlou SN; Urban RJ; Rivier JC; Vale WW; Veldhuis JD
J Clin Endocrinol Metab; 1992 Oct; 75(4):993-7. PubMed ID: 1400893
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of prolactin secretion by estrogen in hypogonadal women.
Yen SS; Ehara Y; Siler TM
J Clin Invest; 1974 Feb; 53(2):652-5. PubMed ID: 11344580
[TBL] [Abstract][Full Text] [Related]
16. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
Nakano R; Yagi S; Nishi T
Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia-induced precocious puberty: studies on the mechanism(s) by which prolactin enhances ovarian progesterone responsiveness to gonadotropins in prepubertal rats.
Advis JP; Richards JS; Ojeda SR
Endocrinology; 1981 Apr; 108(4):1333-42. PubMed ID: 6781872
[TBL] [Abstract][Full Text] [Related]
18. Impaired steroidogenic function of corpora lutea from hyperprolactinemic baboons induced by sulpiride.
Horie K; Ban C; Taii S; Mori T; Aso T
Endocrinol Jpn; 1986 Apr; 33(2):211-4. PubMed ID: 3093203
[TBL] [Abstract][Full Text] [Related]
19. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
Onda H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
